The following is a summary of “Physiological comparison of noninvasive ventilation and high-flow nasal oxygen on inspiratory ...

InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its ...

The man kept getting worse; in fact, he seemed to deteriorate before their eyes. Initially, he received supplemental oxygen ...

In the EU, GOHIBIC (vilobelimab) has been granted marketing authorization under exceptional circumstances for the treatment ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

Background Limited evidence exists on the comparative effectiveness of noninvasive ventilation (NIV) vs invasive mechanical ventilation (IMV) in acute exacerbation of chronic obstructive pulmonary ...

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to ...

Flexible Bronchoscopy is a non-invasive test that visualises the airways and lung interior through a flexible tube.

Scientists have identified the first U.S. case of the invasive longhorned tick carrying a bacteria that causes Ehrlichiosis.

Regional Trends Shaping the Idiopathic Pulmonary Fibrosis Management Industry: North America leads with innovation, while Asia-Pacific shows rapid diagnostic adoption and rising treatment demand.” — ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that ...

A new report by the Connecticut Agricultural Experiment Station (CAES) shows evidence of an invasive longhorned tick infected ...